LYVE1 and neoplasm: A combination of LMW-HA and LYVE-1 promoted the proliferation and migration of lymphatic endothelial cells, thereby promoting lymphangiogenesis [187], while proliferation of melanoma cells is inhibited by ectodomain of LYVE-1 that was shed from M2-like tumour-associated macrophages.